The estimated Net Worth of Sean Tucker is at least $753 Tysiąc dollars as of 22 April 2022. Dr Tucker owns over 40,000 units of Vaxart Inc stock worth over $119,973 and over the last 7 years he sold VXRT stock worth over $102,000. In addition, he makes $530,720 as Sr. VP & Chief Scientific Officer at Vaxart Inc.
Sign up
Dr Tucker VXRT stock SEC Form 4 insiders trading
Dr has made over 6 trades of the Vaxart Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 40,000 units of VXRT stock worth $30,800 on 22 April 2022.
The largest trade he's ever made was exercising 40,000 units of Vaxart Inc stock on 22 April 2022 worth over $30,800. On average, Dr trades about 5,621 units every 100 days since 2018. As of 22 April 2022 he still owns at least 127,631 units of Vaxart Inc stock.
You can see the complete history of Dr Tucker stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Sean N. Tucker biography
Dr. Sean N. Tucker is the Sr. VP & Chief Scientific Officer at Vaxart Inc.
What is the salary of Dr Tucker?
As the Sr. VP & Chief Scientific Officer of Vaxart Inc, the total compensation of Dr Tucker at Vaxart Inc is $530,720. There are 2 executives at Vaxart Inc getting paid more, with Wouter Latour having the highest compensation of $747,711.
How old is Dr Tucker?
Dr Tucker is 53, he's been the Sr. VP & Chief Scientific Officer of Vaxart Inc since . There are 9 older and 3 younger executives at Vaxart Inc. The oldest executive at Vaxart Inc is Anne VanLent, 72, who is the Independent Director.
What's Dr Tucker's mailing address?
Sean's mailing address filed with the SEC is C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080.
Insiders trading at Vaxart Inc
Over the last 7 years, insiders at Vaxart Inc have traded over $322,706,538 worth of Vaxart Inc stock and bought 8,979,091 units worth $2,899,807 . The most active insiders traders include Capital, Llc Armistice Capi..., Steven Lo oraz Wouter Latour. On average, Vaxart Inc executives and independent directors trade stock every 57 days with the average trade being worth of $1,309,363. The most recent stock trade was executed by W. Mark Watson on 18 June 2024, trading 20,000 units of VXRT stock currently worth $13,600.
What does Vaxart Inc do?
since its founding in 2004, vaxart has pursued a vision of advancing vaccines—to make them as tablets rather than injections. the company’s proprietary oral vaccine delivery platform is suitable to deliver any recombinant vaccine, positioning vaxart to introduce oral forms of multiple vaccines in the rapidly growing global vaccines market.
What does Vaxart Inc's logo look like?
Complete history of Dr Tucker stock trades at Vaxart Inc
Vaxart Inc executives and stock owners
Vaxart Inc executives and other stock owners filed with the SEC include:
-
Wouter Latour,
Chairman of the Board -
Cezar Andrei Floroiu M.B.A.,
CEO, Pres, Principal Financial Officer & Director -
Dr. Sean N. Tucker,
Sr. VP & Chief Scientific Officer -
Margaret A. Echerd,
Sr. VP & Principal Accounting Officer -
Sean Tucker,
Chief Scientific Officer -
Margaret Echerd,
Principal Accounting Officer, Vice President, Controller -
Anne VanLent,
Independent Director -
Michael Finney,
Independent Director -
Robert Yedid,
Lead Independent Director -
Todd Davis,
Independent Director -
Karen Wilson,
Independent Director -
Keith Maher,
Director -
Steven Boyd,
Director -
Andrei Floroiu,
Chief Executive Officer, Principal Financial Officer, Director -
Edward B. Berg,
Sr. VP & Gen. Counsel -
John M. Harland M.B.A., CPA,
Consultant -
Dr. James F. Cummings M.D.,
Chief Medical Officer -
Dr. Rajesh Kapoor Ph.D.,
Sr. VP of Quality -
Dr. Richard M. Schwartz,
Sr. VP of Technical Operations -
Brant Biehn,
Sr. VP of Bus. Operations -
Shaily Jaini Garg,
Sr. VP of Clinical Devel. & Project Management -
Julie M Cherrington,
Director -
Edward B Berg,
SVP, General Counsel -
John M Harland,
Chief Financial Officer -
Richard J Markham,
Director -
Geoffrey F Cox,
Director -
John P Richard,
Director -
Phillip E Lee,
Chief Financial Officer -
David E. Wheadon,
Director -
James F. Cummings,
Chief Medical Officer -
W. Mark Watson,
Director -
Elaine J Heron,
Director -
Steven Lo,
President, Chief Exec Officer -
Fuad Ahmad,
Interim CFO